Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody

Giant cell arteritis (GCA) is the most common form of systemic vasculitis in adults, affecting preferentially medium-large size arteries. Here we report a case of a female with a diagnosis of GCA based on temporal artery biopsy, successfully treated with tocilizumab, a humanized anti-interleukin-6 r...

Descripción completa

Detalles Bibliográficos
Autores principales: Lurati, Alfredomaria, Bertani, Luca, Re, Katia Angela, Marrazza, Mariagrazia, Bompane, Daniela, Scarpellini, Magda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420619/
https://www.ncbi.nlm.nih.gov/pubmed/22937454
http://dx.doi.org/10.1155/2012/639612
_version_ 1782240885678800896
author Lurati, Alfredomaria
Bertani, Luca
Re, Katia Angela
Marrazza, Mariagrazia
Bompane, Daniela
Scarpellini, Magda
author_facet Lurati, Alfredomaria
Bertani, Luca
Re, Katia Angela
Marrazza, Mariagrazia
Bompane, Daniela
Scarpellini, Magda
author_sort Lurati, Alfredomaria
collection PubMed
description Giant cell arteritis (GCA) is the most common form of systemic vasculitis in adults, affecting preferentially medium-large size arteries. Here we report a case of a female with a diagnosis of GCA based on temporal artery biopsy, successfully treated with tocilizumab, a humanized anti-interleukin-6 receptor antibody.
format Online
Article
Text
id pubmed-3420619
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-34206192012-08-30 Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody Lurati, Alfredomaria Bertani, Luca Re, Katia Angela Marrazza, Mariagrazia Bompane, Daniela Scarpellini, Magda Case Rep Rheumatol Case Report Giant cell arteritis (GCA) is the most common form of systemic vasculitis in adults, affecting preferentially medium-large size arteries. Here we report a case of a female with a diagnosis of GCA based on temporal artery biopsy, successfully treated with tocilizumab, a humanized anti-interleukin-6 receptor antibody. Hindawi Publishing Corporation 2012 2012-04-03 /pmc/articles/PMC3420619/ /pubmed/22937454 http://dx.doi.org/10.1155/2012/639612 Text en Copyright © 2012 Alfredomaria Lurati et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Lurati, Alfredomaria
Bertani, Luca
Re, Katia Angela
Marrazza, Mariagrazia
Bompane, Daniela
Scarpellini, Magda
Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody
title Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody
title_full Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody
title_fullStr Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody
title_full_unstemmed Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody
title_short Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody
title_sort successful treatment of a patient with giant cell vasculitis (horton arteritis) with tocilizumab a humanized anti-interleukin-6 receptor antibody
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420619/
https://www.ncbi.nlm.nih.gov/pubmed/22937454
http://dx.doi.org/10.1155/2012/639612
work_keys_str_mv AT luratialfredomaria successfultreatmentofapatientwithgiantcellvasculitishortonarteritiswithtocilizumabahumanizedantiinterleukin6receptorantibody
AT bertaniluca successfultreatmentofapatientwithgiantcellvasculitishortonarteritiswithtocilizumabahumanizedantiinterleukin6receptorantibody
AT rekatiaangela successfultreatmentofapatientwithgiantcellvasculitishortonarteritiswithtocilizumabahumanizedantiinterleukin6receptorantibody
AT marrazzamariagrazia successfultreatmentofapatientwithgiantcellvasculitishortonarteritiswithtocilizumabahumanizedantiinterleukin6receptorantibody
AT bompanedaniela successfultreatmentofapatientwithgiantcellvasculitishortonarteritiswithtocilizumabahumanizedantiinterleukin6receptorantibody
AT scarpellinimagda successfultreatmentofapatientwithgiantcellvasculitishortonarteritiswithtocilizumabahumanizedantiinterleukin6receptorantibody

Ejemplares similares